Kamada (KMDA) EBT Growth (1y) (2013 - 2026)
Kamada (KMDA) EBT Growth (1y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -324.14% |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | -5.04% |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -1.93% |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | -8.74% |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 70.52% |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 1.69% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 124.00% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Kamada | 462.32 Mn | 432.85 Mn | 22.47 Mn | 77.11% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 28.15% |
| Mar 31, 2026 | -18.48% |
| Dec 31, 2025 | 92.52% |
| Sep 30, 2025 | 61.31% |
| Jun 30, 2025 | 77.12% |
| Mar 31, 2025 | 171.14% |
| Dec 31, 2024 | -51.05% |
| Sep 30, 2024 | 19.75% |
| Jun 30, 2024 | -99.76% |
| Mar 31, 2024 | 135,901.78% |
| Dec 31, 2023 | 54.63% |
| Sep 30, 2023 | 540,227.87% |
| Jun 30, 2023 | -51.83% |
| Mar 31, 2023 | -100.10% |
| Dec 31, 2022 | 167.42% |
| Sep 30, 2022 | -99.93% |
| Jun 30, 2022 | 309.84% |
| Mar 31, 2022 | -30.41% |
| Dec 31, 2021 | -352.30% |
| Sep 30, 2021 | -87.92% |